Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2025 ∙ Pan, H. Yu, Y. Li, X. Wang, M. Wen, C. Dai, Q. Huang, L.
Vaccination and rheumatoid arthritis: an updated systematic review and meta-analysis of data from 25,949,597 participants
All age groups Safety
Rating:
Low
2025 ∙ Golla, E. B. Geremew, H. Abate, A. Ali, M. A. Simegn, M. B. Tilahun, W. M. Kuse, S. A. Wondie, S. G.
Vaccination dropout and associated factors among children in Ethiopia: a systematic review and meta-analysis (2014-2024)
Africa Ethiopia Children Coverage
Rating:
Not applicable
2025 ∙ Virk, S. Milewski, A. Khan, N. Cheung, C. Wright, D. N. Kaur, G.
Vaccination in Forcibly Displaced, Pediatric Populations: A Systematic Review and Meta-Analysis
Newborn Children Adolescents Coverage
Rating:
Not applicable
2025 ∙ Bynum, C. Bail, J. Prevost, S.
Vaccines and voices: A systematic literature review of sociocultural influences on adult immunization hesitancy
Americas United States of America Adults Older adults Acceptance
Rating:
Not applicable
2025 ∙ Zorger, A. M. Hirsch, C. Baumann, M. Feldmann, M. Bröckelmann, P. J. Mellinghoff, S. Monsef, I. Skoetz, N. Kreuzberger, N.
Vaccines for preventing infections in adults with haematological malignancies
Adults Older adults Efficacy/effectiveness Safety
Rating:
High
2025 ∙ Hirsch, C. Zorger, A. M. Baumann, M. Park, Y. S. Bröckelmann, P. J. Mellinghoff, S. Monsef, I. Skoetz, N. Kreuzberger, N.
Vaccines for preventing infections in adults with solid tumours
Adults Older adults Pneumococcal disease Haemophilus influenzae type B Meningococcal disease Pertussis Hepatitis B Tetanus Poliomyelitis Diphtheria Influenza Herpes zoster COVID-19 Efficacy/effectiveness Safety
Rating:
High
2025 ∙ de Bondt, D. Naslazi, E. Jansen, E. Kupets, R. McCurdy, B. Stogios, C. de Kok, I. Hontelez, J.
Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies
Adolescents Adults Human papillomavirus (HPV) Coverage Modeling Efficacy/effectiveness
Rating:
Not applicable
2025 ∙ Li, Y. Liu, Z. Zhou, L. Li, R.
Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis
Western Pacific China All age groups Economic aspects Acceptance
Rating:
Not applicable
2024 ∙ Nangsue, C. Srisurapanont, K. Sudjaritruk, T.
A Comparison of the Immunogenicity and Safety of an Additional Heterologous versus Homologous COVID-19 Vaccination among Non-Seroconverted Immunocompromised Patients after a Two-Dose Primary Series of mRNA Vaccination: A Systematic Review and Meta-Analysis
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Low
2024 ∙ Ewongwo, A. Sahor, A. F. Ngwa, W. Nwachukwu, C.
A guide to global access to HPV vaccination to all women in low- and middle-income countries; a minireview of innovation and equity
All age groups Low and Middle Income Countries Human papillomavirus (HPV) Acceptance
Rating:
Not applicable
Loading...